Crowdonomics
WatchlistPortfolio
All companies
SurgiQuality logo

SurgiQuality

Operating

SurgiPrice, Inc.

Healthcare · Rockville, MD

Visit website

SurgiQuality is an AI-powered platform that helps patients make informed decisions by providing multiple expert opinions and tools to compare surgeons using validated outcomes scoring, specific to the procedure they need. By partnering with leading healthcare institutions, self-insured employers and health plans, SurgiQuality brings transparency to the surgical process, helping to reduce unnecessary procedures and improve patient outcomes.

Post-money valuation ⓘ
$25.0M
As of Sep 2025 · from Reg CF Offering (2025) · pre-money + amount raised, not a traded price
Total raised
$6,729
Across 1 round since 2025
Latest share price
$1.30
Reg CF · Series CF Preferred Stock · Jun 2025 offering price

Financials

FY2023–FY2024 · from SEC filings · hover any figure for its source
−$41K
−$2.7M
2023
−$18K
−$1.9M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2023 reviewed
FY2024 reviewed
Income statement
Revenue
-$40,917
-$17,648
Cost of goods sold
$40,917
$22,818
Net income
-$2,727,560
-$1,852,931
Taxes paid
$0
$0
Balance sheet
Cash
$894,717
$382
Accounts receivable
$0
$2,430
Total assets
$1,179,485
$250,036
Short-term debt
$2,509,585
$2,783,315
Long-term debt
$1,679,292
$2,121,175
Total liabilities
$4,188,877
$4,904,490
Other
Headcount
—
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$25.0M
pre-money
Reg CF · Series CF Preferred · Jun 2025

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Series CF Preferred Stock · Jun 2025Closedvia StartEngine
Raised $6.7K / $1.2MInvestors 4Post-money $25M

Team

3 people
Sanjay Prasad
Chief Executive Officer, Director, Chairman of the Board, and Principal Accounting Officer

Practicing Surgeon for 33 years; Clinical Assistant Prof GW University Hospital; Founder of Ambulatory Surgery Center; Author, ""Resetting Healthcare Post COVID 19 Pandemic, The Patinet Guide""; Founder of Race and Health Foundation; Chief Editor and Co-author, ""Race Forward: The Health Equity Guide for Employers""

Marshall James Besch II
Data Operations

With over 30 years of extensive experience in healthcare delivery, administration, quality, improvement, and financial management specialize in driving operational excellence and fostering patient centric care based on outcomes. With a commitment to delivering high-quality, scientifically based, transparent care across all aspects of healthcare industry, and passionate about driving positive outcomes of ensuring exceptional patient experiences. I am dedicated to enhancing patient, safety, and transparency and surgical outcomes. Proven track record of navigating complex, healthcare environments in fostering a culture of excellence.

Thomas R. Young III
Board member

Physician executive with over 40 yers of experience in multiple organizations as founder , CMO

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 1 annual reports (FY2025)

Missing: 2025

4 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form CJun 23, 20250001665160-25-001233
    EDGAR
Source: SEC EDGARCIK 0002069679DEShare price $1.30Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.